Dublin, Jan. 26, 2016 (GLOBE NEWSWIRE) — Research and Markets (http://www.researchandmarkets.com/research/xs4hnp/autoinjectors_to) has announced the addition of the “Autoinjectors to 2024” report to their offering.
Syringes that can be prefilled on standard fill-and-finish lines have had a dramatic effect on the way injectable drugs are developed, prescribed and administered. This impact has been accelerated by the introduction and evolution of autoinjectors – devices that are designed to accept a standard prefilled syringe and form an outer user-friendly device package that simplifies the injection process. Autoinjectors enable a significantly larger segment of the patient population to self-administer injectables. This report analyzes eleven important therapeutic segments and examines the impact of autoinjectors on injectable drug markets.
What You Will Learn
– What autoinjectors can be paired with prefilled syringes for injectable drug delivery; what are the key market segments, market dynamics and market demographics?
– What are the therapeutic demand drivers and commercial devices in key product segments?
– What are the design factors, material selection issues, technologies and market development issues?
– How big is the market? How is it growing? What will it look like in 2024?
– Who are the leading injectable drug and device participants, their product development activities, business strategies, and corporate alliances and affiliations?
– What is the importance of pharma-device alliances and design partnerships on autoinjector commercialization and market access?
– What is the impact of wirelessly connected autoinjectors on patient care and market growth?
– What are the significant economic, technology, and regulatory factors affecting the market for autoinjectors?
Key Topics Covered:
1. Executive Summary
2. The Market Opportunity
3. Delivery Market Dynamics
– The Economics of Injectable Drugs
– What’s Driving the Growth in Autoinjectors?
– Prefilled Devices Proliferating
– The Trend toward Self-Administration
– Shifting Demographics
– Innovation in Disposable Device Designs
– Therapeutic Demand Drivers
– Competitive Landscape
– Risk Factors
4. Autoinjectors – Commercial Devices
– Manual Injection Autoinjectors
– Automated Injection Autoinjectors
– Reusable Autoinjectors
– Disposable Autoinjectors
– Variable Dose Autoinjectors
– Smart Autoinjectors
– Product Specific Autoinjectors
5. Autoinjector Device Design Factors
– Material Selection Issues
– Part Counts and Device Cost
– Safety Features
– Needle Insertion Depth
– Dose Inspection/Injection Confirmation
– Wireless Connectivity
– Lyophilized Drugs/Reconstitution
– Human Engineering/Ergonomics
6. Autoinjector Drug Delivery – Therapeutic Sector Analysis
– Anaphylaxis/Countermeasures
– Anticoagulants
– Autoimmune Diseases
– Emergency Medicine
– Infectious Diseases
– Hematopoietics
– Hormones
– Neurology
– Reproductive Health
7. Market Factors
– Regulatory Issues
– Device Branding
– Patient Compliance and Ease of Use
– Healthcare Economics
8. Company Profiles
For more information visit http://www.researchandmarkets.com/research/xs4hnp/autoinjectors_to
CONTACT:
CONTACT: Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
